Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2023 Aug 17;43(10):2058–2067. doi: 10.1161/ATVBAHA.123.319341

Figure 4.

Figure 4.

10-year incident CAD risk stratified by LLM use. Forest plot shows 10-year incident CAD risk among LLM-treated (blue) and LLM-untreated (red) UK Biobank participants with a severe hypercholesterolemia subtype compared to non-genetic severe hypercholesterolemia. Cox proportional-hazard ratios with 95% confidence intervals are shown.